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Differential Expression of Ovine Innate Immune Genes by Preterm and
Neonatal Lung Epithelia Infected with Respiratory Syncytial Virus
Abstract
Preterm infants have increased susceptibility to severe manifestations of respiratory syncytial virus (RSV)
infection. The cause(s) for this age-dependent vulnerability is/are not well-defined, but alterations in innate
immune products have been implicated. In sheep, RSV disease severity has similar age-dependent
characteristics and sheep have several related innate molecules for study during pulmonary infection including
surfactant protein A (SP-A), surfactant protein D (SP-D), sheep beta defensin 1 (SBD1), monocyte
chemotactic protein 1 (MCP1), and Toll-like receptor 4 (TLR4). However, the in vivo cellular gene
expression as a response to RSV infection is poorly understood. In this study, the effect of RSV infection on
expression of these innate immune genes was determined for bovine RSV-infected (bRSV+ fluorescence)
epithelial cells, adjacent cells lacking bRSV antigen (adjoining cells lacking fluorescence), and control cells
from non-infected lung using laser capture microdissection (LCM) and real-time RT-PCR. Control lambs had
increased expression of innate immune molecules in full term (term) compared to preterm epithelia with
statistical significance in SBD1, SP-D, and TLR4 mRNA. Infected cells (bRSV+ fluorescent cells) had
consistently higher mRNA levels of SP-A (preterm and term), MCP1 (preterm and term), and SP-D
(preterm). Interestingly, bRSV- cells of infected term lambs had significantly reduced SP-D mRNA expression
compared to bRSV+ and control epithelia, suggesting that RSV infected cells may regulate the adjacent
epithelial SP-D expression. This study defines specific innate immune components (e.g., SBD1, SP-D, and
TLR4) that have differential age-dependent expression in the airway epithelia. Furthermore, cellular bRSV
infection enhanced certain innate immune components while suppressing adjacent cellular SP-D expression
in term animals. These in vivo gene expression results provide a framework for future studies on age-
dependent susceptibility to RSV and RSV pathogenesis.
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ABSTRACT
Preterm infants have increased susceptibility to severe manifestations of respiratory syncytial virus
(RSV) infection. The cause(s) for this age-dependent vulnerability is/are not well-defined, but al-
terations in innate immune products have been implicated. In sheep, RSV disease severity has sim-
ilar age-dependent characteristics and sheep have several related innate molecules for study during
pulmonary infection including surfactant protein A (SP-A), surfactant protein D (SP-D), sheep beta
defensin 1 (SBD1), monocyte chemotactic protein 1 (MCP1), and Toll-like receptor 4 (TLR4). How-
ever, the in vivo cellular gene expression as a response to RSV infection is poorly understood. In
this study, the effect of RSV infection on expression of these innate immune genes was determined
for bovine RSV-infected (bRSV fluorescence) epithelial cells, adjacent cells lacking bRSV antigen
(adjoining cells lacking fluorescence), and control cells from non-infected lung using laser capture
microdissection (LCM) and real-time RT-PCR. Control lambs had increased expression of innate
immune molecules in full term (term) compared to preterm epithelia with statistical significance in
SBD1, SP-D, and TLR4 mRNA. Infected cells (bRSV fluorescent cells) had consistently higher
mRNA levels of SP-A (preterm and term), MCP1 (preterm and term), and SP-D (preterm). Inter-
estingly, bRSV- cells of infected term lambs had significantly reduced SP-D mRNA expression com-
pared to bRSV and control epithelia, suggesting that RSV infected cells may regulate the adja-
cent epithelial SP-D expression. This study defines specific innate immune components (e.g., SBD1,
SP-D, and TLR4) that have differential age-dependent expression in the airway epithelia. Further-
more, cellular bRSV infection enhanced certain innate immune components while suppressing ad-
jacent cellular SP-D expression in term animals. These in vivo gene expression results provide a
framework for future studies on age-dependent susceptibility to RSV and RSV pathogenesis.
1Department of Veterinary Pathology, College of Veterinary Medicine, Iowa State University Ames, Iowa.
2Shichinohe Research Unit, National Institute of Animal Health, Shichinohe, Aomori, Japan.
3National Animal Disease Center, ARS/USDA, Ames, Iowa.
INTRODUCTION
RESPIRATORY SYNCYTIAL VIRUS (RSV), an envelopedsingle-strand RNA pneumovirus, is a globally im-
portant respiratory pathogen. RSV typically causes upper
respiratory tract disease in most people; however, it is of
significant concern in children, especially preterm and
young infants who have an increased risk for severe dis-
ease including bronchiolitis, pneumonia, and rarely death
(3, 7). Premature and young infants have impaired host
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defense elements that include: reduced monocyte and neu-
trophil function (19, 24), limited complement activity
(33), altered cytokine expression (20), and immature ep-
ithelial cell phenotypes (9). Pulmonary epithelial cells are
a major source of antimicrobial peptides and proteins
(AMPs) such as  defensins and surfactant proteins A and
D (SP-A and SP-D, respectively). Furthermore, respira-
tory epithelia can express signaling molecules (e.g., Toll-
like receptor 4 [TLR4]) or chemotactic mediators (e.g.,
monocyte chemotactic protein 1 [MCP1]), which regu-
late the immune response to RSV infection and these in-
nate immune components are being increasingly appreci-
ated for their direct and indirect activities against viral
infections (11, 22). While these epithelial derived factors
are implicated in host defense against RSV, their cell-spe-
cific expression during early clearance of natural RSV
infection is not well defined. Recently, levels of ovine 
SP-A, SP-D and sheep  defensin 1 (SBD1) mRNA were
increased during clearance of parainfluenza virus 3 (PIV3)
infections in newborn lambs, indicative of a role in reso-
lution of viral infection (13).
Investigation of the mechanisms of RSV infection re-
quires a documented animal model with comparable dis-
ease manifestations. Late term fetal and preterm lambs
have proved valuable as pulmonary models for the study
of surfactant gene ontogeny (4, 17) and for study of RSV
infection (5, 21). Sheep have consistency with human
RSV disease including similar age-dependent suscepti-
bility, lesions, and expression of innate immunity genes.
Recent work has demonstrated enhanced microscopic le-
sions with reduced RSV antigen clearance in preterm ver-
sus neonatal lambs, similar to RSV disease in infants (28).
The purpose of this work was to determine the ex-
pression of innate immune genes by pulmonary epithelia
with or without bovine RSV (bRSV) infection in preterm
and full term (term) lambs. We examined mRNA ex-
pression levels from RSV antigen  and  epithelial
cells retrieved by laser capture microdissection (LCM) in
preterm and term neonatal lambs.
MATERIALS AND METHODS
Lambs and bRSV. Use of lambs was approved by
Iowa State University’s Animal Care and Use Commit-
tee. The surgical delivery of preterm lambs, viral inocu-
lation and incubation time was performed as previously
described to reproduce a standard animal RSV model for
impaired clearance of RSV infection and assess cellular
innate immune gene expression (28). Briefly, preterm
lambs were derived from healthy date-mated adult com-
mercial ewes via surgical uterotomy (day 138 of gesta-
tion, term  147) or by natural birth for term lambs.
Within the first hour, fresh colostrum (200 ml) was
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given via a stomach tube and ceftiofur (2.2 mg/kg/day,
intramuscular) was given to prevent potential bacterial
complications (32). Lambs were acclimated one day and
then inoculated with bovine respiratory syncytial virus
[strain 375, 103–4 TCID50/ml] or sterile media (sham con-
trol) by means of intratracheal deposition (20 ml). At 6
days post-inoculation, the lambs were euthanatized with
sodium pentobarbital. Lung tissues were collected from
preterm lambs with bRSV (n  6) or sterile media (n 
6) inoculation; and term lambs (147 days) with bRSV
(n  4) or sterile media (n  4) inoculation.
Laser capture microdissection (LCM). Lung tissues
were embedded in OCT media, snap frozen and tissue sec-
tions cut on a cryostat (6 m). The bRSV-infected cells
(bRSV) were identified by immunofluorescence using a
monoclonal anti–bRSV-4 antibody (kindly provided by
Dr. Kenneth Platt, Iowa State University) and a biotiny-
lated goat anti-mouse secondary IgG (Kirkegaard and
Perry, Gaithersburg, MD). After appropriate washes, tis-
sues were exposed to a Cy3-streptavidin reagent (Rock-
land, Inc., Gilbertsville, PA). Stained cells were retrieved
by LCM (PixCell II, Arcturus, Mountain View, CA) and
approximately 100–300 fluorescent cells (containing
bRSV antigen), as identified during LCM by IF-IHC and
morphology, were laser captured onto HS LCM caps (Arc-
turus). Then using a different HS LCM cap, the nonstain-
ing cells (adjacent epithelium lacking bRSV antigen) were
collected. These cells were immediately adjacent to the
previously detached bRSV cells. Last, on yet another dif-
ferent HS LCM cap, lung of sterile media (sham control)
inoculated lambs was collected for epithelial cells. Effort
was made to retrieve similar proportions of bronchiolar
and alveolar epithelium between the bRSV and sterile me-
dia lungs during LCM. After all cells of interest were har-
vested onto HS LCM caps, total RNA was isolated.
Quantiative PCR (qPCR). Total RNA was isolated,
processed for real-time RT-PCR (one-step), and assessed
for mRNA levels of SP-A, SP-D, SBD-1, TLR4, MCP-1a,
and bRSV, as described previously (10). Briefly, RNA was
isolated using components of a commercial kit (Invitro-
gen, Carlsbad, CA). RNA samples were spun down, and
6 l of each was used as “RNA template” in 30-l fluo-
rogenic one-step real-time qPCR reactions as carried out
in 96-well PCR reaction plates (ABI, Forest City, CA) us-
ing a GeneAmp 5700 Sequence Detection System for
detection and relative quantification of mRNA targets
(Table 1). Each plate contained both target and endoge-
nous reference reac-tions for each sample, and negative
no-template control (nuclease-free water) for each target
and endogenous reference were also included. All samples
were represented in duplicate. Each target signal mRNA
level was normalized to its respective ovRPS15 signal
using a recently described mathematical model, value 
[(Etarget)Ct (control-treated)] / [(Eref)Ct (control-treated)] (30).
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Statistical analysis. First, summary statistics (means
and standard errors of the mean) were calculated for each
group to describe the data. Next, a two-way ANOVA was
used to assess for group effects. Where significant group
differences were detected, post-hoc tests (with Bonfer-
roni correction) were performed on groups that had sci-
entific relevance. Unless otherwise noted, statistical sig-
nificance was set at p  0.05.
RESULTS
On the final day of the infection, lambs inoculated with
bRSV had clinical signs (e.g., elevated body tempera-
tures, increased respiration rate, etc.) consistent with pre-
vious work (28). This study applied LCM and real-time
RT-PCR techniques to assess innate immune gene ex-
pression of bRSV antigen positive and adjacent bRSV
antigen negative epithelial cells in pre- and term infected
lambs. This work demonstrates, on the cellular level, dif-
ferential innate immune expression by age and infection
status.
SP-A: In preterm lamb lungs, epithelia containing
bRSV antigen had elevated SP-A mRNA compared to
adjacent epithelia lacking bRSV antigen (p  0.05) and
control epithelia (p  0.01) (Fig. 1). In full term lamb
lungs, the SP-A mRNA expression in epithelia with
bRSV antigen was significantly elevated compared to ad-
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jacent cells lacking bRSV antigen (p  0.05). Similar
changes (close to statistical significance, p  0.06) were
seen compared to epithelia of term control lambs.
SP-D: In preterm lambs, SP-D mRNA expression was
elevated in bRSV antigen positive cells compared to
318
TABLE 1. PRIMERS (FORWARD AND REVERSE) AND PROBES FOR OVINE GENE EXPRESSION ASSESSED BY REAL-TIME RT-PCR
SBD1 Fwd: 5-CCATAGGAATAAAGGCGTCTGTG
Rev: 5-CGCGACAGGTGCCAATCT
Probe: 5-6FAM-CCGAGCAGGTGCCCTAGACACATGA-TAMRA
SP-A Fwd: 5-TGACCCTTATGCTCCTCTGGAT
Rev: 5-GGGCTTCCAAGACAAACTTCCT
Probe: 5-6FAM-TGGCTTCTGGCCTCGAGTGCG-TAMRA
SP-D Fwd: 5-ACGTCTGCAGCTGAGAAT
Rev: 5-TCGGTCATGCTCAGGAAAGC
Probe: 5-6FAM-TTGACTCAGCTGGCCACAGCCCAGAACA-TAMRA
MCP1 Fwd: 5-GCTGTGATTTTCAAGACCATCCT
Rev: 5-GGCGTCCTGGACCCATT
Probe: 5-6FAM-AAAGAGTTTTGTGCAGACCCCAACC-TAMRA
TLR4 Fwd: 5-GAGAAGACTCAGAAAAGCCTTGCT
Rev: 5-GCGGGTTGGTTTCTGCAT
Probe: 5-6FAM-TAAACCCCAGAGTCCAGAAGGAACAGCA-TAMRA
bRSV Nucleocapsid Fwd: 5-CAGTCAAGAATATTATGCTTGGTCATG
Rev: 5-CCTAACTTTTGTGCATATTCATAGACTTC
Probe: 5-6FAM-CAACCTGTTCCATTTCTGCTTGTACGCTG-TAMRA
Ovine Ribo S15 Fwd: 5-CGAGATGGTGGGCAGCAT
Rev: 5-GCTTGATTTCCACCTGGTTGA
Probe: 5-VIC-CCGGCGTCTACAACGGCAAGACC-TAMRA
*6FAM or VIC  5 Fluorescent reporter dye, TAMRA  Fluorescent quencher dye.
FIG. 1. Relative SP-A mRNA expression in control and
bRSV infected (bRSV antigen [] and bRSV antigen [] cells)
pulmonary epithelia of preterm and term lambs. bRSV cells
had enhanced expression over either control (preterm, p  0.01;
term, p  0.06) or bRSV cells (preterm, p  0.05; term, p 
0.05)
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bRSV antigen negative cells (p  0.01) or control lamb
epithelia (p  0.01) (Fig. 2). In full term lambs, the bRSV
antigen negative cells had reduced expression compared
to either control (p  0.01) or bRSV antigen positive
cells (p  0.01). Furthermore, the control term lambs had
significantly elevated SP-D mRNA compared to preterm
lambs (p  0.00001).
SBD1: SBD1 mRNA had significantly enhanced ex-
pression with age (preterm versus full term) in the con-
trol (p  0.05) (Fig. 3). No other scientifically relevant
comparisons were statistically significant.
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MCP1: In preterm lambs, MCP1 mRNA expression of
the bRSV epithelia was significantly increased com-
pared to control (p  0.05) epithelia (Fig. 4). The
bRSV epithelia of term lambs had increased expression
over control (p  0.01), bRSV- (p  0.01) and preterm
bRSV epithelia (p  0.05).
TLR4: Epithelia from the control lambs had significantly
reduced TLR4 mRNA expression in preterm compared to
term lambs (p  0.05) (Fig. 5). In term lambs, TLR4
mRNA expression was significantly reduced in bRSV anti-
gen negative cells compared to control epithelia (p  0.05).
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FIG. 2. Relative SP-D mRNA expression in control and bRSV infected (bRSV antigen [] and bRSV antigen [] cells)
pulmonary epithelia of preterm and term lambs. In control epithelia, term lambs had enhanced SP-D mRNA expression com-
pared to preterm animals (p  0.00001). In preterm epithelia, bRSV cells had enhanced SP-D expression over control (p 
0.01) or bRSV epithelia (p  0.01). In term epithelia, bRSV cells of infected lambs had reduced expression compared to con-
trol (p  0.01) or bRSV epithelia (p  0.01).
FIG. 3. Relative SBD1 mRNA expression in control and bRSV infected (BRSV antigen [] and bRSV antigen [] cells)
pulmonary epithelia of preterm and term lambs. Term lambs had greater SBD1 mRNA expression compared to preterm lambs
in the control group (p  0.05).
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DISCUSSION
In this study, the influence of developmental age and
bRSV infection status on SP-A, SP-D, SBD1, MCP1, and
TLR4 mRNA expression were determined using laser
capture microdissection (LCM) retrieved cells and real
time quantitative polymerase chain reaction (qPCR).
Concerning surfactant proteins, SP-A mRNA expres-
sion generally increased in bRSV infected cells compared
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to adjacent non bRSV infected cells or cells from con-
trol lambs. This is similar to recent in vitro work with
cultured human type II cells where SP-A mRNA was sig-
nificantly increased in RSV infected cells (2). In that
same study, SP-A secretion was reduced compared to
controls and the authors suggested this disparity could be
due to inefficient SP-A translation or increased protease
activity by RSV infected cells. Assessment of transla-
tional products of these innate immune genes was not at-
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FIG. 4. Relative MCP1 mRNA expression in control and bRSV infected (bRSV antigen [] and bRSV antigen [] cells)
pulmonary epithelia of preterm and term lambs. The bRSV preterm epithelia had enhanced MCP1 mRNA expression over con-
trol (p  0.05). The bRSV epithelia of term lambs had increased expression over control (p  0.01), bRSV (p  0.01) and
Preterm bRSV epithelia (p  0.05).
FIG. 5. Relative TLR4 mRNA expression in control and bRSV infected (bRSV antigen [] and bRSV antigen [] cells)
pulmonary epithelia of preterm and term lambs. The control term epithelia had enhanced expression compared to control preterm
(p  0.05) and bRSV term epithelia (p  0.05).
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tempted in the current study. However, the neonatal lamb
model of PIV3 infection suggests that whole-lung SP-A
mRNA expression increases during clearance of PIV3
virus while whole-lung SP-A protein levels remains un-
changed—similar to the in vitro study (2,13). RSV in-
fected cells have increased activity of many initiator and
effector caspases, which have functional protease activ-
ity and thus may, in part, explain reduced SP-A transla-
tional product (18). These caspases also participate in the
mechanism of apoptosis, a proposed method in the even-
tual clearance of RSV infected cells (32). The increase
in SP-A mRNA of bRSV infected cells of both preterm
and term lambs suggests it is a fundamental cellular in-
nate response to bRSV infection, but does not, however,
explain age-dependent RSV disease severity.
SP-D expression in preterm lambs was similar to the
expression pattern generally detected for SP-A with en-
hanced mRNA expression in bRSV infected cells. Inter-
estingly, there was a distinct age-dependent difference of
SP-D expression in the control group. SP-D plays an im-
portant role in RSV defense as SP-D knockout mice have
reduced RSV clearance and increased inflammatory le-
sions compared to wild type mice (23). Similarly, the ob-
servation of reduced SP-D expression in preterm lambs
compared to term lambs in the current study corresponds
to the reduced clearance of bRSV previously described
in preterm versus term lambs (28). This suggests that in-
sufficient SP-D expression in preterm neonates may be
a potential factor in the development of RSV disease.
In full term lambs, SP-D mRNA expression did not
differ between control or bRSV infected epithelia; how-
ever, cells lacking bRSV antigen had reduced SP-D
mRNA expression. Recent in vitro work on type II pneu-
mocytes suggests SP-D regulation is more adapted for
rapid alterations in synthesis, metabolism and secretion
compared to SP-A (6). Furthermore, recent evidence sug-
gests that the upstream promotor of the SP-D gene can
be regulated by certain AP-1 elements including c-Jun
and c-Fos as well as cytokines such as IL-4 (6, 16). Ac-
cordingly, adjacent inflammatory products may, in part,
regulate SP-D expression in adjacent non bRSV infected
cells of term lambs. The decreased SP-D mRNA expres-
sion of cells adjacent to bRSV infected cells is a novel
finding and warrants further investigation.
Expression of SBD1 was developmentally regulated in
control epithelia of lambs. The developmental regulation
of SBD1 seen in this study is similar to sheep  defensin
2 (SBD2), another  defensin of sheep that is preferen-
tially expressed in the gastrointestinal tract (27). bRSV
infection of epithelial cells did not cause significant al-
teration of SBD1 mRNA expression when compared to
control epithelia or cells lacking bRSV antigen. Recently,
whole lung homogenates from lambs with acute
Mannheimia hemolytica pneumonia were shown to have
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reduced SBD1 expression compared to uninfected con-
trols (1). This contrasted another study in which PIV3 in-
fected lambs had increased SBD1 expression late in the
progression of the disease (13). The collective evidence
on SBD1 regulation suggests that acute inflammation
does not promote mRNA expression; however subacute
to chronic processes such as epithelial regeneration/pro-
liferation and differentiation may be more realistically as-
sociated with the increases in SBD1 mRNA expression
(1, 13, 26). While this study did not detect statistically
significant alteration of SBD1 expression in relation to
bRSV status, the developmental regulation of SBD1 ex-
pression suggests that it cannot be ruled out as a partic-
ipant in severe preterm RSV disease. Future work should
focus on the later stages of bRSV infection/resolution to
see if SBD1 expression is increased at later time periods.
MCP1 is a chemokine implicated in the pathogenesis
of severe RSV infection of young infants and the secreted
G-protein by RSV virus is thought to be responsible for
significant upregulation of MCP1 expression (12, 25, 29).
Enhanced pulmonary MCP1 expression can affect im-
mune responses by leukocyte recruitment, mast cell de-
granulation and can influence the TH1/TH2 response (31).
In the current study, full term lambs had increased MCP1
expression in bRSV infected epithelia over epithelial
from adjacent non bRSV infected cells or control ep-
ithelia, and similar tendencies were detected in preterm
lambs. The similar response by both age groups suggests
that MCP1 expression may be involved in the typical
bRSV clearance. Interestingly, the level of MCP1 ex-
pression by bRSV infected epithelia was significantly
higher in term than in preterm lambs. This was unex-
pected since lambs/infants with increased maturity typi-
cally have reduced disease severity and MCP1 in human
infants is often associated with severe RSV disease (12).
One speculation may be that enhanced MCP1 mRNA ex-
pression by term over preterm lambs represents a pro-
tective rather than detrimental effect. Further efforts are
needed to confirm and better define this discovery.
TLR4 is an important pattern recognition receptor of
the innate immune system and is thought to play an im-
portant role in the innate immune response against RSV
(15). In the present study, the significant developmental
regulation of TLR4 expression in control epithelia is con-
sistent with TLR4 ontogeny in the mouse lung (14).
While there was significant developmental regulation in
control epithelia, the only significant effect of bRSV in-
fection status was decreased TLR4 expression in
non–bRSV infected epithelia when compared to control
epithelia. Recently, work in mice has suggested that the
role of TLR4 in RSV clearance by different species may
not be as universal as previously thought (8). The role of
TLR4 in bRSV infection of lambs needs to be further ad-
dressed.
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In conclusion, this novel study demonstrates the in vivo
regulation of innate immune gene expression by devel-
opmental age as well as bRSV infection status. This study
reaffirms age dependent regulation of innate immune
genes that coincides with preterm RSV disease suscepti-
bility, suggestive of interaction. Furthermore, this study
shows that bRSV infection can alter not only infected ep-
ithelia, but also adjacent cellular innate immune gene ex-
pression.
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